NCT01494402View on ClinicalTrials.gov

Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Bioequivalence Study
Interventions
DRUG

D961S

Oral gelatine capsule

DRUG

Esomeprazole

Oral HPMC capsule

DRUG

Buffered acetylsalicylic acid

Tablet

Trial Locations (1)

Unknown

Study site, Hakata

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY